Chargement en cours...
Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery
OBJECTIVE: Stereotactic radiosurgery (SRS) is routinely used to treat brain metastases from melanoma due to their radioresistant nature. The median survival for these patients is 4–6 months, according to earlier studies. The aim of this study was to evaluate prognostic factors that influence surviva...
Enregistré dans:
| Publié dans: | J Neurosurg |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469983/ https://ncbi.nlm.nih.gov/pubmed/27903181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.8.GKS161359 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|